Streetbeat News

Products Services

AEY

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) announced that its subsidiary, Fulton Technologies, has signed multi-year agreements with some of the largest optical communications OEMs in the US. Under these agreements, Fulton's Broadband division is authorized to provide fiber design, engineering, and construction services throughout the US. This comes after the recent expansion of Broadband services by Fulton and is expected to improve legacy deployment methods.

Portfolio Pulse from Happy Mohamed

October 13, 2023 | 1:02 pm

NVVE

Nuvve Holding Corp. (NASDAQ:NVVE) has been granted a new European patent for its vehicle-to-grid (V2G) technology. The company's V2G patents include comprehensive solutions for the control of power flow to electric vehicles and the grid, management of EV charging, and calculation of available power capacity of aggregated EVs. Nuvve's V2G patent portfolio extends globally, with coverage across a wide array of European countries.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:46 pm

ERJ

Embraer (NYSE:ERJ) has extended its multi-year contract with Sky High Aviation for the Pool Program. The agreement allows the Dominican Republic-based airline to continue receiving support for repairable components for its E-190 and E-175 aircraft. Embraer has been supporting Sky High Aviation since it became the first E-Jet operator in the Caribbean last year. The Pool Program currently supports over 60 airlines worldwide.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:44 pm

NTLA

Intellia Therapeutics has received Priority Medicines designation from the European Medicines Agency for NTLA-2002, an investigational in vivo CRISPR genome editing treatment for Hereditary Angioedema.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:40 pm

GPAK

Gamer Pakistan Inc. (NASDAQ:GPAK) announced that its subsidiary K2 Gamer has received its first major sponsorship from 313 Mobiles for the Super Mega Pakistan Universities Esports Championship 2023. The championship is expected to attract the best gamers from across the higher education institutions of Pakistan and help to further develop the esports ecosystem and community in the country.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:38 pm

ADN

Advent Technologies Holdings, Inc. (NASDAQ:ADN) participated in the inaugural Clean Transition Dialogue on Hydrogen organized by the European Commission. The event focused on the role of the hydrogen sector in Europe's energy independence. Advent's CEO, Dr. Vasilis Gregoriou, briefed EU President Ursula von der Leyen on the progress of projects endorsed by the EU under the Important Project of Common European Interest (IPCEI) in hydrogen technology. He also discussed the delay in securing funding for Advent's EU-ratified Green HiPo project in Greece, which aims to develop, design, and produce HTPEM fuel cell systems and electrolyser systems.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:37 pm

TRVI

Trevi Therapeutics, Inc. (NASDAQ:TRVI) has announced the 52-week results from its phase 2b/3 PRISM open-label extension study of Haduvio for the treatment of prurigo nodularis. The data shows continued reduction in itch over 52 weeks for the participants who remained in the study. The safety data were generally consistent with the safety profile of Haduvio observed in the 14-week portion of PRISM and previous trials of Haduvio.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:37 pm

NKTR

Nektar Therapeutics (NASDAQ:NKTR) presented new data for rezpegaldesleukin (REZPEG), a first-in-class selective regulatory T-cell therapy, at the 2023 EADV Congress. The data showed dose-dependent efficacy across all endpoints for REZPEG in patients with atopic dermatitis. The therapy was well tolerated with no severe, serious, or fatal adverse events reported. Based on these results, Nektar is initiating two Phase 2 studies in atopic dermatitis and in alopecia areata.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:36 pm

ANIX

Anixa Biosciences (NASDAQ:ANIX) has completed the treatment of the first patient cohort in its ongoing clinical trial of CAR-T therapy for ovarian cancer, in partnership with Moffitt Cancer Center. The first cohort received the same dose of engineered T-cells, with no dose-limiting toxicities observed. The trial will now begin enrolling patients in the second dose cohort, who will receive three times the cell dose compared to the first cohort. The study aims to evaluate the therapy's safety, determine the maximum tolerated dose of T-cells targeting the follicle stimulating hormone receptor (FSHR), and preliminarily assess clinical activity.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:35 pm

GOOG

GOOGL

MSFT

Google, a subsidiary of Alphabet Inc., is testing generative AI functionalities for its search tool, allowing users to generate images and write drafts directly from the search engine. The Search Generated Experience (SGE) is designed to let users generate a specific image based on their search query. This feature is similar to Microsoft Corp.’s Bing Chat, which now has the latest Dall-E 3 model from OpenAI. Google is also developing a tool called “About this image” that intends to assist users in evaluating the context and credibility of images.

Portfolio Pulse from Benzinga Neuro

October 13, 2023 | 12:13 pm